Financial Reports
CDB continued to maintain liquidity levels above the regulatory minimum and stringent ALCO targets were maintained during the year.
STATEMENT OF CHANGES IN EQUITY
| Reserves | ||||||||||
| Note | Stated capital Rs. ’000 |
Other capital reserve Rs. ’000 |
Revaluation reserve Rs. ’000 |
Fair value reserve Rs. ’000 |
Hedge reserve Rs. ’000 |
Statutory reserve fund Rs. ’000 |
Regulatory loss allowance reserve Rs. ’000 |
Retained earnings Rs. ’000 |
Total equity Rs. ’000 |
|
| Balance as at 1 April 2021 | 2,350,363 | – | 609,661 | 3,924 | – | 1,881,996 | – | 9,206,276 | 14,052,220 | |
| Total comprehensive income for the year 2021/22 |
||||||||||
| Profit for the year | – | – | – | – | – | – | – | 3,612,080 | 3,612,080 | |
| Other comprehensive income for the year |
||||||||||
| Fair value changes in hedge reserve |
– | – | – | – | (145,759) | – | – | – | (145,759) | |
| Increase in revaluation surplus | – | – | 284,076 | – | – | – | – | – | 284,076 | |
| Less: Deferred tax on revaluation |
– | – | (68,178) | – | – | – | – | – | (68,178) | |
| Equity investments at FVOCI – net change in fair value |
– | – | – | 75,240 | – | – | – | – | 75,240 | |
| Net actuarial loss on defined benefit plan |
38 | – | – | – | – | – | – | – | 319,405 | 319,405 |
| Total comprehensive income for the year 2021/22 |
– | – | 215,898 | 75,240 | (145,759) | – | – | 3,931,485 | 4,076,864 | |
| Transactions with equity holders of the Company |
||||||||||
| Employee share option plan | – | 33,211 | – | – | – | – | – | – | 33,211 | |
| Exercise of share options | 11,584 | (2,357) | – | – | – | – | – | – | 9,227 | |
| Dividend to equity holders for the year – 2021/22 |
– | – | – | – | – | – | – | (523,447) | (523,447) | |
| Transfers during the year | 41.3 & 41.5 | – | – | – | (22,633) | – | 180,604 | – | (157,971) | – |
| Total transactions with equity holders |
11,584 | 30,854 | – | (22,633) | – | 180,604 | – | (681,418) | (481,009) | |
| Balance as at 31 March 2022 | 2,361,947 | 30,854 | 825,559 | 56,531 | (145,759) | 2,062,600 | – | 12,456,343 | 17,648,075 | |
| Balance as at 1 April 2022 | 2,361,947 | 30,854 | 825,559 | 56,531 | (145,759) | 2,062,600 | – | 12,456,343 | 17,648,075 | |
| Adjustment for Surcharge Tax levied under the Surcharge Tax Act No. 14 of 2022 | 15.4 | – | – | – | – | – | – | – | (715,053) | (715,053) |
| Adjusted balance as at 1 April 2022 | 2,361,947 | 30,854 | 825,559 | 56,531 | (145,759) | 2,062,600 | – | 11,741,290 | 16,933,022 | |
| Total comprehensive income for the year 2022/23 | ||||||||||
| Profit for the year | – | – | – | – | – | – | – | 1,626,883 | 1,626,883 | |
| Other comprehensive income for the year | ||||||||||
| Fair value changes in hedge reserve |
– | – | – | – | 248,464 | – | – | – | 248,464 | |
| Less: Deferred tax on revaluation | – | – | (64,153) | – | – | – | – | – | (64,153) | |
| Financial investments at FVOCI – net change in fair value |
– | – | – | (244,256) | – | – | – | (20,362) | (264,618) | |
| Deferred tax on financial investment at FVOCI |
– | – | – | 73,418 | – | – | – | – | 73,418 | |
| Net actuarial loss on defined benefit plan |
38 | – | – | – | – | – | – | – | (100,835) | (100,835) |
| Total comprehensive income for the year 2022/23 | – | – | (64,153) | (170,838) | 248,464 | – | – | 1,505,686 | 1,519,159 | |
| Transactions with equity holders of the Company |
||||||||||
| Dividend to equity holders for the year – 2022/23 |
– | – | – | – | – | – | – | (261,960) | (261,960) | |
| Transfers during the year | 41.5 & 41.6 | – | – | – | – | – | 81,343 | 1,606,402 | (1,687,745) | – |
| Total transactions with equity holders | – | – | – | – | – | 81,343 | 1,606,402 | (1,949,705) | (261,960) | |
| Balance as at 31 March 2023 | 2,361,947 | 30,854 | 761,406 | (114,307) | 102,705 | 2,143,943 | 1,606,402 | 11,297,271 | 18,190,221 | |
The Notes to the Financial Statements an integral part of these Financial Statements.
Figures in brackets indicate deductions.